Could be true, but no.
As you said a couple of posts down (up?), MYX share price before the Teva announcement was some $1.40, after the announcement it quickly goes to $2. That's a 42% jump in both share price as well as the equivalent enterprise value.
i.e before Teva, MYX has some 810m shares. At $1.40 that's ev of $1.134B.
After Teva it has some 1.5b shares. That's ev of $1.5b. or 32% gain on the $1.40 share price at the current $1 price.
Fundamentals Are Strong, page-50
-
- There are more pages in this discussion • 822 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.81 |
Change
0.430(9.82%) |
Mkt cap ! $409.2M | |||
| Open | High | Low | Value | Volume |
| $4.44 | $4.81 | $4.44 | $1.701M | 362.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 115 | $4.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.81 | 6332 | 3 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |